NGVT vs PSA · rev $1.41B vs rev $4.82B
Ingevity Corp (NGVT) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Ingevity Corp (NGVT) is a specialty chemicals company listed on NYSE.
PSA (PSA) common stock.
Latest reported NGVT revenue for 2024-12-31 was $1.41B. Net income was -$430.3M. Revenue was down 16.9% from 2023-12-31 to 2024-12-31. NGVT currently screens at market cap $2.52B.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
NGVT currently screens at market cap $2.52B. PSA currently screens at market cap $0.
Not investment advice. Open the NGVT and PSA stock pages for the full models.
Not investment advice.